Unibioscreen And Drais Pharmaceuticals Partner To Develop And Commercialize Unbs5162 For Treatment Of Cancer Drais Pharmaceuticals, Inc. and Unibioscreen S.A. announced that they have entered into a global agreement to develop and commercialize UNBS5162, one of Unibioscreen's investigational drug and potential breakthrough treatments for cancer. UNBS5162 was discovered by Unibioscreen and is currently in Phase I trials in the United States in cancer patients with advanced solid tumors or lymphoma.
Source: www.medicalnewstoday.com
# posted by Network @ 4:00 AM
